A computational approach to drug repurposing against SARS-CoV-2 RNA dependent RNA polymerase (RdRp)
Giovanni Ribaudo, Alberto Ongaro, Erika Oselladore, Giuseppe Zagotto, Maurizio Memo, Alessandra Gianoncelli
Abstract
docking study underline that compounds formerly developed as kinase inhibitors may interact with RdRp.Communicated by Ramaswamy H. Sarma.
Topics & Concepts
Drug repositioningRepurposingRNA polymeraseRNA-dependent RNA polymeraseCoronavirusComputational biologyRNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Drug discoveryBiologyDocking (animal)VirologyCoronavirus disease 2019 (COVID-19)DrugPharmacologyBioinformaticsMedicineDiseaseInfectious disease (medical specialty)GeneGeneticsPathologyNursingEcologySARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsRNA and protein synthesis mechanisms